Spruce Biosciences to Participate in May Investor Conferences

Rhea-AI Summary

Spruce Biosciences, Inc. (Nasdaq: SPRB) will participate in two upcoming investor conferences in May, featuring Fireside chats and 1x1 meetings. The events will include the JMP Securities Life Sciences Conference on May 13-14, 2024, and the RBC Capital Markets Global Healthcare Conference on May 14-15, 2024. The CEO, Javier Szwarcberg, M.D., M.P.H., will be presenting at these conferences, with webcasts available on the company's investor relations website.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in two upcoming investor conferences taking place in May.

• The JMP Securities Life Sciences Conference
  Date: May 13-14, 2024
  Format: Fireside chat (May 14, 2024 at 10:30 a.m. ET) and 1x1 meetings

• 2024 RBC Capital Markets Global Healthcare Conference
  Date: May 14-15, 2024
  Format: Fireside chat (May 15, 2024 at 8:30 a.m. ET) and 1x1 meetings

The live webcast for each conference presentation can be accessed on the events section of the company’s investor relations website and will be available for replay after the conclusion of the live presentations for approximately 90 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal, once-daily therapy for patients suffering from classic congenital adrenal hyperplasia (CAH) and other endocrine disorders. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501727100/en/

Media Contact

Katie Beach Oltsik

Inizio Evoke Comms

(937) 232-4889

Katherine.Beach@inizioevoke.com

media@sprucebio.com

Investors

Samir Gharib

President and CFO

Spruce Biosciences, Inc.

investors@sprucebio.com

Source: Spruce Biosciences, Inc.

FAQ

When will Spruce Biosciences participate in investor conferences in May 2024?

Spruce Biosciences will participate in two upcoming investor conferences in May 2024.

What is the stock symbol of Spruce Biosciences?

The stock symbol of Spruce Biosciences is SPRB.

Who will be presenting for Spruce Biosciences at the investor conferences?

The CEO, Javier Szwarcberg, M.D., M.P.H., will be presenting for Spruce Biosciences at the investor conferences.

Where can the live webcasts for the conference presentations be accessed?

The live webcasts can be accessed on the events section of Spruce Biosciences' investor relations website.